Recent News

DeSimone named recipient of 22nd Heinz Award

DeSimone named recipient of 22nd Heinz Award

UNC Lineberger's Joseph DeSimone, PhD, has been named the recipient of the 22nd Heinz Award in the Technology, the Economy and Employment category.

DeSimone named recipient of 22nd Heinz Award - Read More…

Savings less than expected for generic oral chemotherapy

Savings less than expected for generic oral chemotherapy

A study led by UNC Lineberger's Stacie Dusetzina, PhD, compared the cost of the generic and brand-name version of capecitabine, which was one of the first high-priced chemotherapy pills to come off patent in the United States. Their findings offer a glimpse into what could be happening with generic competition in this specialty drug market.

Savings less than expected for generic oral chemotherapy - Read More…

Research collaboration launched in South Africa to study Kaposi sarcoma

Research collaboration launched in South Africa to study Kaposi sarcoma

UNC Lineberger's Dirk Dittmer, PhD, has launched a collaboration with researchers in South Africa to investigate the biology of Kaposi sarcoma, a cancer caused by a herpes virus and associated with infection with HIV.

Research collaboration launched in South Africa to study Kaposi sarcoma - Read More…

Innovative cancer data resource expands, gains a new name

Innovative cancer data resource expands, gains a new name

Academics and policymakers are using the Cancer Information & Population Health Resource, or CIPHR, to knit together data from multiple public and private sources to examine a wide range of complex issues tied to improving cancer outcomes in North Carolina.

Innovative cancer data resource expands, gains a new name - Read More…